| Aug 26 |
SI-BONE (SIBN) Receives FDA Nod for Its TNT Implant System
|
| Aug 22 |
SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024
|
| Aug 20 |
SI-BONE receives 510(k) clearance and FDA breakthrough device designation
|
| Aug 20 |
SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System
|
| Aug 8 |
Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 64.45%: Here's is How to Trade
|
| Aug 7 |
SI-BONE Second Quarter 2024 Earnings: Beats Expectations
|
| Aug 6 |
Q2 2024 SI-BONE Inc Earnings Call
|
| Aug 6 |
SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024
|
| Aug 6 |
SI-BONE, Inc. (SIBN) Q2 2024 Earnings Call Transcript
|
| Aug 5 |
Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates
|
